Effects of paclitaxel on cytokine synthesis by unprimed human monocytes, T lymphocytes, and breast cancer cells

Cancer Immunology Immunotherapy

Volumn 46, Issue 2, 1998, Pages 104-112

  White, Charise M ^a   Martin, Brian K ^b   Lee, Li Fen ^a   Haskill, J Stephen ^a,b   Ting, Jenny P Y ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Chemokines; Cytokines; Human; Monocytes macrophages; T lymphocytes

Indexed keywords

ANTINEOPLASTIC AGENT; CHEMOKINE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; MESSENGER RNA; PACLITAXEL;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CYTOKINES; FEMALE; GENE EXPRESSION; HUMANS; INTERLEUKIN-1; INTERLEUKIN-8; MONOCYTES; PACLITAXEL; RNA, MESSENGER; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0031955204     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050468     Document Type: Article

References (46)

1. Allen JN, Moore SA, Wewers MD (1993) Taxol enhances but does not induce interleukin-1 beta and tumor necrosis factor-alpha production. J Lab Clin Med 122:374-381
2. Bhalla K, Ibrado AM, Tourkina E, Tang C, Mahoney ME, Huang Y (1993) Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells. Leukemia 7:563-568
3. Bjorkdahl O, Wingren AG, Hedhund G, Ohlsson L, Dohlsten M (1997) Gene transfer of a hybrid interleukin-1 beta gene to B16 mouse melanoma recruits leucocyte subsets and reduces tumour growth in vivo (in Process Citation). Cancer Immunol Immunother 44:273-281
4. Bogdan C, Ding A (1992) Taxol, a microtubule-stabilizing antineoplastic agent, induces expression of tumor necrosis factor alpha and interleukin-1 in macrophages. J Leukoc Biol 52:119-121
5. Boyum A (1968) Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl 97:77-89
6. Caplow M, Shanks J, Ruhlen R (1994) How taxol modulates microtubule disassembly. J Biol Chem 269:23399-23402
7. Carr MW, Roth SJ, Luther E, Rose SS, Springer TA (1994) Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci USA 91:3652-3656
8. Colasante A, Mascetra N, Brunetti M, Lattanzio G, Diodoro M, Caltagirone S, Musiani P, Aiello FB (1997) Transforming growth factor beta 1, interleukin-8 and interleukin-1, in non-small-cell lung tumors (in Process Citation). Am J Respir Crit Care Med 156:968-973
9. Cooperstock MS (1974) Inactivation of endotoxin by polymyxin B. Antimicrob Agents Chemothe 6:422-425
10. Cozzolino F, Torcia M, Aldinucci D, Ziche M, Almerigogna F, Bani D, Stern DM (1990) Interleukin 1 is an autocrine regulator of human endothelial cell growth. Proc Natl Acad Sci USA 87:6487-6491
11. Dinarello CA (1991) Interleukin-1 and interleukin-1 antagonism. Blood 77:1627-1652
12. Dinarello CA (1993) Modalities for reducing interleukin 1 activity in disease (review). Immunol Today 14:260-264
13. Fenton MJ (1992) Review: transcriptional and post-transcriptional regulation of interleukin 1 gene expression (review). Int J Immunopharmacol 14:401-411
14. Graves DT, Jiang Y (1995) Chemokines, a family of chemotactic cytokines (review). Crit Rev Oral Biol Med 6:109-118
15. Grunvald E, Chiaramonte M, Hieny S, Wysocka M, Trinchieri G, Vogel SN, Gazzinelli RT, Sher A (1996) Biochemical characterization and protein kinase C dependency of monokine-inducing activities of Toxoplasma gondii. Infect Immun 64:2010-2018
16. Horwitz SB (1994) Taxol (paclitaxel): mechanisms of action (review). Ann Oncol 5 [Suppl 6]:S3-6
17. Huizing MT, Misser VH, Pieters RC, Bokkel Huinink WW ten, Veenhof CH, Vermorken JB, Pinedo HM, Beijnen JH (1995) Taxanes: a new class of antitumor agents (review). Cancer Invest 13:381-404
18. Jordan MA, Toso RJ, Thrower D, Wilson L (1993) Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc Natl Acad Sci USA 90:9552-95566
19. Jun CD, Choi BM, Kim HM, Chung HT (1995) Involvement of protein kinase C during taxol-induced activation of murine peritoneal macrophages. J Immunol 154:6541-6547
20. Kaye SB (1995) Taxoids. Eur J Cancer 31:824-826
21. Lee L-F, Schuerer-Maly CC, Lofquist AK, Haften-Day C van, Ting JP, White CM, Martin BK, Haskill JS (1996) Taxol-dependent transcriptional activation of IL-8 expression in a subset of human ovarian cancer. Cancer Res 56:1303-1308
22. + T lymphocytes. FASEB J 8:1055-1060
23. Lofquist AK, Mondai K, Morris JS, Haskill JS (1995) Transcription-independent turnover of 1 kappa B alpha during monocyte adherence: implications for a translational component regulating I kappa B alpha/MAD-3 mRNA levels. Mol Cell Biol 15:1737-1746
24. Long BH, Fairchild CR (1994) Paclitaxel inhibits progression of mitotic cells to G1 phase by interference with spindle formation without affecting other microtubule functions during anaphase and telephase. Cancer Res 54:4355-4361
25. Manthey CL, Brandes ME, Perera PY, Vogel SN (1992) Taxol increases steady-state levels of lipopolysaccharide-inducible genes and protein-tyrosine phosphorylation in murine macrophages. J Immunol 149:2459-2465
26. Manthey CL, Qureshi N, Stutz PL, Vogel SN (1993) Lipopolysaccharide antagonists block taxol-induced signaling in murine macrophages. J Exp Med 178:695-702
27. Markman M, Francis P, Rowinsky E, Hakes T, Reichman B, Jones W, Lewis JL Jr, Rubin S, Curtin J, Barakat R, et al (1994) Intraperitoneal Taxol (paclitaxel) in the management of ovarian cancer. Ann Oncol 5 [Suppl 6]:S55-58
28. Markman M, Francis P, Rowinsky E, Hoskins W (1995) Intraperitoneal paclitaxel: a possible role in the management of ovarian cancer? (Review). Semin Oncol 22[Suppl 6]:84-87
29. Moxey-Mims MM, Simms HH, Frank MM, Lin EY, Gaither TA (1991) The effects of IL-1, IL-2, and tumor necrosis factor on polymorphonuclear leukocyte Fc gamma receptor-mediated phagocytosis. IL-2 down-regulates the effect of tumor necrosis factor. J Immunol 147:1823-1830
30. Munkarah A, Chuang L, Lotzova E, Cook K, Morris M, Wharton JT (1994) Comparative studies of taxol and taxotere on tumor growth and lymphocyte functions. Gynecol Oncol 55:211-216
31. Ogilvie AC, Hack CE, Wagstaff J, Mierlo GJ van, Erenberg AJ, Thomsen LL, Hoekman K, Rankin EM (1996) IL-1 beta does not cause neutrophil degranulation but does lead to IL-6, IL-8, and nitrite/nitrate release when used in patients with cancer. J Immunol 156:389-394
32. Ohmori Y, Strassman G, Hamilton TA (1990) cAMP differentially regulates expression of mRNA encoding IL-1 alpha and IL-1 beta in murine peritoneal macrophages. J Immunol 145:3333-3339
33. Patton LM, Saggart BS, Ahmed NK, Leff JA, Repine JE (1995) Interleukin-1 beta-induced neutrophil recruitment and acute lung injury in hamsters. Inflammation 19:23-29
34. Perera PY, Qureshi N, Vogel SN (1996) Paclitaxel (Taxol)-induced NF-kappaB translocation in murine macrophages. Infect Immun 64:878-884
35. Pluznik DH, Lee NS, Sawada T (1994) Taxol induces the hematopoietic growth factor granulocyte-macrophage colony-stimulating factor in murine B-cells by stabilization of granulocyte-macrophage colony-stimulating factor nuclear RNA. Cancer Res 54:4150-4154
36. Rao S, Krauss NE, Heerding JM, Swindell CS, Ringel I, Orr GA, Horwitz SB (1994) 3′-(p-azidobenzamido)taxol photolabels the N-terminal 31 amino acids of beta-tubulin. J Biol Chem 269:3132-3134
37. Rao S, Orr GA, Chaudhary AG, Kingston DG, Horwitz SB (1995) Characterization of the taxol binding site on the microtubule. 2-(m-Azidobenzoyl)taxol photolabels a peptide (amino acids 217-231) of beta-tubulin. J Biol Chem 270:20235-20238
38. Seidman AD (1994) Single-agent use of Taxol (paclitaxel) in breast cancer (review). Ann Oncol 5 [Suppl 6]:S17-22
39. Skerka C, Irving SG, Bialonski A, Zipfel PF (1993) Cell type specific expression of members of the IL-8/NAP-1 gene family. Cytokine 5:112-116
40. Strieter RM, Polverini PJ, Arenberg DA, Walz A, Opdenakker G, Van Damme J, Kunkel SL (1995) Role of C-X-C chemokines as regulators of angiogenesis in lung cancer (review). J Leukoc Biol 57:752-762
41. Su N, Ojeifo JO, MacPherson A, Zwiebel JA (1994) Breast cancer gene therapy: transgenic immunotherapy (review). Breast Cancer Res Treat 31:349-356
42. Towata T, Hayashi N, Katayama K, Takehara T, Miyoshi E, Kawanishi Y, Ueda K, Kasahara A, Fusamoto H, Kamada T (1993) Effects of cytokines on HLA class I antigen expression on Huh6 and HB611 cells. Gastroenterol Jpn 28:242-248
43. Ulmer AJ, Had HD (1979) Discontinuous density gradient separation of human mononuclear leucocytes using Percoll as gradient medium. J Immunol Methods 30:1-10
44. Van Meir E, Ceska M, Effenberger F, Walz A, Grouzmann E, Desbaillets I, Frei K, Fontana A, Tribolet N de (1992) Interleukin-8 is produced in neoplastic and infectious diseases of the human central nervous system. Cancer Res 52:4297-4305
45. Wang X, Feuerstein GZ, Gu JL, Lysko PG, Yue TL (1995) Interleukin-1 beta induces expression of adhesion molecules in human vascular smooth muscle cells and enhances adhesion of leukocytes to smooth muscle cells. Atherosclerosis 115:89-98
46. Yagisawa M, Yuo A, Kitagawa S, Yazaki Y, Togawa A, Takaku F (1995) Stimulation and priming of human neutrophils by IL-1 alpha and IL-1 beta: complete inhibition by IL-1 receptor antagonist and no interaction with other cytokines. Exp Hematol 23:603-608